Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution
- 200 Downloads
Multiple approaches such as mathematical deconvolution and mechanistic oral absorption models have been used to predict in vivo drug dissolution in the gastrointestinal (GI) tract. However, these approaches are often validated by plasma pharmacokinetic profiles, but not by in vivo drug dissolution due to the limited data available regarding the local GI environment. It is also challenging to predict and validate in vivo dissolution in different regions of the GI tract (stomach, duodenum, jejunum, and ileum). In this study, the dynamic fluid compartment absorption and transport (DFCAT) model was used to predict the in vivo dissolution profiles of ibuprofen, which was administered as an 800-mg immediate-release tablet to healthy subjects, in different regions of the GI tract. The prediction was validated with concentration time-courses of ibuprofen (BCS class 2a) in different regions of the GI tract that we have obtained over the past few years. The computational model predicted that the dissolution of ibuprofen was minimal in the stomach (2%), slightly more in the duodenum (6.3%), and primarily dissolved in the jejunum (63%) and the ileum (25%). The detailed model prediction of drug dissolution in different regions of GI can provide a quantitative reference of in vivo dissolution that may provide valuable insight in developing in vitro tests for drug product optimization and quality.
KEY WORDSmechanistic deconvolution modeling absorption dissolution
This work was partially supported by grant no. HHSF223201510157C and grant no. HHSF223201310144C by the U.S. Food and Drug Administration (FDA). Bart Hens acknowledges the financial support from the Flemish Research Council (FWO–applicant number 12R2119N).
- 2.EMEA. Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action. 2019. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-dissolution-specification-generic-solid-oral-immediate-release-products-systemic_en.pdf. Accessed 4 September 2019
- 3.FDA. Guidance document: dissolution testing of immediate release solid oral dosage forms. 2019. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/dissolution-testing-immediate-release-solid-oral-dosage-forms. Accessed 4 September 2019
- 14.Klueglich M, Ring A, Scheuerer S, Trommeshauser D, Schuijt C, Liepold B, et al. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol. 2005;45(9):1055–61.CrossRefGoogle Scholar
- 18.Hens B, Tsume Y, Bermejo M, Paixao P, Koenigsknecht MJ, Baker JR, et al. Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs. Mol Pharm. 2017.Google Scholar
- 19.Sun D, Baker JR, Wen B, Frances A, Zhang H, Yu A, et al. In vivo dissolution and systemic absorption of immediate release ibuprofen in human gastrointestinal tract under fed and fasted conditions. Mol Pharm. 2017;4(12):4295–304.Google Scholar
- 20.FDA. Bioanalytical Method Validation Guidance for Industry. 2019. Available from: https://www.regulations.gov/document?D=FDA-2013-D-1020-0039.
- 21.Heikkila T, Karjalainen M, Ojala K, Partola K, Lammert F, Augustijns P, et al. Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid. Int J Pharm. 2011;405(1–2):132–6. Accessed 4 September 2019CrossRefGoogle Scholar
- 22.Hens B, Brouwers J, Anneveld B, Corsetti M, Symillides M, Vertzoni M, et al. Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. Eur J Pharm Sci: official journal of the European Federation for Pharmaceutical Sciences. 2014;63:233–42.CrossRefGoogle Scholar
- 26.Rivera-Leyva JC, García-Flores M, Valladares-Méndez A, Orozco-Castellanos LM, Martínez-Alfaro M. Comparative studies on the dissolution profiles of oral ibuprofen suspension and commercial tablets using biopharmaceutical classification system criteria. Indian J Pharm Sci. 2012;74(4):312–8.CrossRefGoogle Scholar